This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ali-Osman, F. Articles by Gray, G. S. Search for Related Content PubMed PubMed Citation Articles by Ali-Osman, F. Articles by Gray, G. S.

Decreased DNA Interstrand Cross-Linking and Cytotoxicity Induced in Human Brain Tumor Cells by 1,3-Bis(2-chloroethyl)-1-nitrosourea after in Vitro Reaction with Glutathione¹

Neuro-Oncology Research Laboratory, Department of Neurological Surgery, University of Washington, Seattle, Washington 98195

Although both direct and glutathione S-transferase (GST)-catalyzed interactions between many electrophiles and GSH generally result in inactivation of the former, there are several reports of compounds whose electrophilic, alkylating, and cytotoxic activities are potentiated by GSH. This study investigates the effects of direct in vitro interaction between GSH and BCNU at physiological pH (7.2) and temperature (37°C) and how this affects the cytotoxic and DNA cross-linking activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in target human malignant brain tumor cells. The kinetics and dose-response relationship of this interaction were determined by measuring residual GSH and residual BCNU-cytotoxicity in a GSH/BCNU mixture over a 45-min period and at varying BCNU concentrations. The results demonstrate that reaction of BCNU with four times its molar concentration of GSH for 45 min significantly inactivates BCNU, as expressed by a 32% decrease in induction of cellular DNA cross-linking, a 21% increase in DNA synthesis, and a 15% increase in clonogenic survival of human brain tumor cells compared to incubates of BCNU alone. Equine liver (EL)-GST increased the inactivation of BCNU only slightly (insignificant at p = 0.05). These results suggest that, in contrast to agents such as the alkyl-N-nitro-N'-nitrosoguanidines which become more potent alkylators after reacting with GSH, the 2-chloroethylnitrosoureas (CENUs) undergo inactivation by GSH. We propose that such interactions between GSH and the CENUs may constitute an important aspect of CENU metabolism and provide a potential means by which brain tumor cells can circumvent CENU toxicity and exhibit resistance to this class of agents.

¹ This research was supported by National Cancer Institute, National Institutes of Health Grant CA-46410 (F. A-O.).

² To whom requests for reprints should be addressed, at Neuro-Oncology Laboratory, Department of Neurological Surgery, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195.

³ Recipient of a Medical Student Research Training Award, University of Washington, Seattle.

Received 12/12/88. Revised 6/ 8/89. Accepted 8/ 2/89.

This article has been cited by other articles:

				P. Yang, J. O. Ebbert, Z. Sun, and R. M. Weinshilboum Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review J. Clin. Oncol., April 10, 2006; 24(11): 1761 - 1769. [Abstract] [Full Text] [PDF]

				M. D. Bacolod, S. P. Johnson, A. E. Pegg, M. E. Dolan, R. C. Moschel, N. S. Bullock, Q. Fang, O. M. Colvin, P. Modrich, D. D. Bigner, et al. Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations Mol. Cancer Ther., September 1, 2004; 3(9): 1127 - 1135. [Abstract] [Full Text] [PDF]

				M. D. Bacolod, S. P. Johnson, F. Ali-Osman, P. Modrich, N. S. Bullock, O. M. Colvin, D. D. Bigner, and H. S. Friedman Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma Mol. Cancer Ther., July 1, 2002; 1(9): 727 - 736. [Abstract] [Full Text] [PDF]

				D.-I. YANG, J.-H. YIN, S. MISHRA, R. MISHRA, and C. Y. HSU NO-Mediated Chemoresistance in C6 Glioma Cells Ann. N.Y. Acad. Sci., May 1, 2002; 962(1): 8 - 17. [Abstract] [Full Text] [PDF]

				C. L. Nutt, M. Noble, A. F. Chambers, and J. G. Cairncross Differential Expression of Drug Resistance Genes and Chemosensitivity in Glial Cell Lineages Correlate with Differential Response of Oligodendrogliomas and Astrocytomas to Chemotherapy Cancer Res., September 1, 2000; 60(17): 4812 - 4818. [Abstract] [Full Text]

				R. Kessler, M.-F. Hamou, M. Albertoni, N. de Tribolet, M. Arand, and E. G. Van Meir Identification of the Putative Brain Tumor Antigen BF7/GE2 as the (De)Toxifying Enzyme Microsomal Epoxide Hydrolase Cancer Res., March 1, 2000; 60(5): 1403 - 1409. [Abstract] [Full Text]